These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 21329785

  • 1. The 5-HT6 receptor as a target for developing novel antiobesity drugs.
    Heal D, Gosden J, Smith S.
    Int Rev Neurobiol; 2011; 96():73-109. PubMed ID: 21329785
    [No Abstract] [Full Text] [Related]

  • 2. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders.
    Heal DJ, Smith SL, Fisas A, Codony X, Buschmann H.
    Pharmacol Ther; 2008 Feb; 117(2):207-31. PubMed ID: 18068807
    [Abstract] [Full Text] [Related]

  • 3. 5-HT6 receptor ligands as antidementia drugs.
    Mitchell ES.
    Int Rev Neurobiol; 2011 Feb; 96():163-87. PubMed ID: 21329788
    [No Abstract] [Full Text] [Related]

  • 4. 5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential antiobesity agents.
    Nilsson BM.
    J Med Chem; 2006 Jul 13; 49(14):4023-34. PubMed ID: 16821762
    [No Abstract] [Full Text] [Related]

  • 5. Discovery, design and synthesis of Y-shaped peroxisome proliferator-activated receptor δ agonists as potent anti-obesity agents in vivo.
    Ham J, Hwang H, Kim E, Kim JA, Cho SJ, Ko J, Lee W, Lee J, Holla H, Banerjee J, Kim S, Yang I, Lee HJ, Shin K, Choi H, Nam SJ, Tak J, Hahn D, Oh T, Won DH, Lee TG, Choi J, Park MS, Seok C, Chin J, Kang H.
    Eur J Med Chem; 2012 Jul 13; 53():190-202. PubMed ID: 22534184
    [Abstract] [Full Text] [Related]

  • 6. New drug targets for the treatment of obesity.
    Powell AG, Apovian CM, Aronne LJ.
    Clin Pharmacol Ther; 2011 Jul 13; 90(1):40-51. PubMed ID: 21654742
    [Abstract] [Full Text] [Related]

  • 7. Design and synthesis of orally-active and selective azaindane 5HT2c agonist for the treatment of obesity.
    Liu KK, Cornelius P, Patterson TA, Zeng Y, Santucci S, Tomlinson E, Gibbons C, Maurer TS, Marala R, Brown J, Kong JX, Lee E, Werner W, Wenzel Z, Vage C.
    Bioorg Med Chem Lett; 2010 Jan 01; 20(1):266-71. PubMed ID: 19914063
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hunter-killer peptide (HKP) for targeted therapy.
    Ellerby HM, Bredesen DE, Fujimura S, John V.
    J Med Chem; 2008 Oct 09; 51(19):5887-92. PubMed ID: 18828573
    [No Abstract] [Full Text] [Related]

  • 10. Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines.
    Correia ML, Haynes WG.
    Expert Opin Emerg Drugs; 2005 Aug 09; 10(3):643-60. PubMed ID: 16083333
    [Abstract] [Full Text] [Related]

  • 11. Medicinal chemistry strategies to 5-HT(6) receptor ligands as potential cognitive enhancers and antiobesity agents.
    Holenz J, Pauwels PJ, Díaz JL, Mercè R, Codony X, Buschmann H.
    Drug Discov Today; 2006 Apr 09; 11(7-8):283-99. PubMed ID: 16580970
    [Abstract] [Full Text] [Related]

  • 12. Discovery of novel, orally available benzimidazoles as melanin concentrating hormone receptor 1 (MCHR1) antagonists.
    Sasmal PK, Sasmal S, Rao PT, Venkatesham B, Roshaiah M, Abbineni C, Khanna I, Jadhav VP, Suresh J, Talwar R, Muzeeb S, Receveur JM, Frimurer TM, Rist Ø, Elster L, Högberg T.
    Bioorg Med Chem Lett; 2010 Sep 15; 20(18):5443-8. PubMed ID: 20724156
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Design and synthesis of orally efficacious benzimidazoles as melanin-concentrating hormone receptor 1 antagonists.
    Wu WL, Burnett DA, Caplen MA, Domalski MS, Bennett C, Greenlee WJ, Hawes BE, O'Neill K, Weig B, Weston D, Spar B, Kowalski T.
    Bioorg Med Chem Lett; 2006 Jul 15; 16(14):3674-8. PubMed ID: 16690315
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Models and strategies in the development of antiobesity drugs.
    Agahi A, Murphy KG.
    Vet Pathol; 2014 May 15; 51(3):695-706. PubMed ID: 23860008
    [Abstract] [Full Text] [Related]

  • 17. Discovery and optimization of novel 4-[(aminocarbonyl)amino]-N-[4-(2-aminoethyl)phenyl]benzenesulfonamide ghrelin receptor antagonists.
    Pasternak A, Goble SD, deJesus RK, Hreniuk DL, Chung CC, Tota MR, Mazur P, Feighner SD, Howard AD, Mills SG, Yang L.
    Bioorg Med Chem Lett; 2009 Nov 01; 19(21):6237-40. PubMed ID: 19767208
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vascular targeting of adipose tissue as an anti-obesity approach.
    Daquinag AC, Zhang Y, Kolonin MG.
    Trends Pharmacol Sci; 2011 May 01; 32(5):300-7. PubMed ID: 21349592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.